ISB News

$500K Proof of Concept Grants Awarded to ISB Scientists

Photo: ISB’s Jennifer Smith speaks to Jose Banda, superintendent of Seattle Public Schools, in this archived photo. Jennifer just received a $250,000 grant from the Life Sciences Discovery Fund.

The Life Sciences Discovery Fund announced the recipients of $1.25 million in Proof of Concept grants. ISB’s Brady Bernard, of the Shmulevich Group, and Jennifer Smith, of the Aitchison Group, each will receive grants totaling almost $500,000. From the LSDF press release:

“For-profit and non-profit organizations in Washington state will receive $1.25M in Proof of Concept grant funding to accelerate the translation of promising health-related technologies from concept to commercialization, the Life Sciences Discovery Fund (LSDF) announced today. Also announced was $2.4M in Opportunity grants for two major research and development initiatives.”
Brady Bernard’s project: Development of Interactive Exploration and Analysis Apps for Cancer Genomics

Objective: To develop web-based tools for analysis of cancer genetic data to advance understanding of tumor biology, accelerate new discoveries, and, in the long term, facilitate personalized therapy

Jennifer Smith’s project: Development of an Indicator Cell Assay for Early Detection of Alzheimer’s Disease from Blood Samples

Objective: To develop a blood-based assay for pre-symptomatic Alzheimer’s disease to permit earlier intervention for affected individuals, monitor responses to treatment, and support drug trials

Read the full press release.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.